Pfizer and Moderna, the two pharmaceutical companies closest to gaining U.S. clearance for a Covid-19 vaccine, won’t attend a White House summit intended to build confidence in the shots.
With the Food and Drug Administration expected to decide on whether to allow the companies’ vaccines to be distributed in the coming days, there was worry that regulators and executives shouldn’t be seen rubbing elbows at the Tuesday meeting.
…The focus of the gathering shifted after Peter Marks, the head of the FDA center that reviews vaccines, volunteered to make a presentation…Since it would be would inappropriate to have vaccine company executives touting their shots while in the same room with their regulator, a decision was made not to include any drugmakers in the meeting, the official said on a call with reporters on Monday.
Predictably, Trump’s setup their “summit” to try to make it appear they had done something right in the fight against COVID-19. And fumbled the ball.
RTFA, though. Pfizer had already notified organizers they wouldn’t be attending. Something similar from Moderna. Both of these firms should be making announcements over the next week or two.
Transparency note: I own shares in Moderna in my retirement investment account.